By targeting serine/threonine kinase RSKs, kaempferol could potentially reduce oxaliplatin-resistant colon cancer cells by suppressing MAPK and PI3K/Akt signaling [233]. The gene discussed is PIK3CA; the disease is malignant colon neoplasm.